Product Program year 2025 Source: CMS Open Payments

myRisk

Device Oncology

Open in the dashboard

General payments

$1,857,629

16,720 payments

Research payments

$0

0 payments

Through program year 2025, $1,857,629 in general payments and $0 in research payments were reported against myRisk (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $78,940 1,879
2024 General $405,985 5,222
2023 General $1,175,204 9,611
2021 General $197,500 8

Breakdown

Who paid General payments · program years 2021–2025
  1. Myriad Genetic Laboratories, Inc. $1,202,600 12,929 payments
  2. Myriad Women's Health, Inc. $655,029 3,791 payments
Top recipients General payments · program year 2025
  1. Dallas Reed Obstetrics & Gynecology · Boston, MA $7,979 10% · 23 payments
  2. Royce Adkins Obstetrics & Gynecology · Nashville, TN $1,706 2% · 5 payments
  3. Peter Hulick Clinical Genetics (M.D.) · Evanston, IL $600 <1% · 1 payment
  4. Catherine Appleton Diagnostic Radiology · Saint Louis, MO $575 <1% · 1 payment
  5. Patrick Villicana Urology · Plantation, FL $557 <1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Obstetrics & Gynecology $11,780 15% · 30 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $10,783 14% · 213 practitioners
  3. Surgery $7,903 10% · 189 practitioners
  4. Physician Assistant $6,288 8% · 136 practitioners
  5. Nurse Practitioner $6,199 8% · 125 practitioners

The top 5 of 58 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $11,570 15% · 179 recipients
  2. Massachusetts $9,868 13% · 36 recipients
  3. Florida $8,854 11% · 218 recipients
  4. New York $6,394 8% · 128 recipients
  5. Illinois $5,268 7% · 71 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

16,720 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record